Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited)

v3.20.2
Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited) - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2020
Jun. 30, 2019
Jun. 30, 2020
Jun. 30, 2019
Income Statement [Abstract]        
Revenue       $ 37
Operating expenses:        
Research and development $ (5,043) $ (24,439) $ (14,786) (41,826)
General and administrative (3,210) (2,939) (6,361) (6,055)
Total operating expenses (8,253) (27,378) (21,147) (47,881)
Operating loss (8,253) (27,378) (21,147) (47,844)
Interest expense, net (4,075) (135) (6,671) (239)
Private placement transaction costs     (2,130)  
Adjustments to fair value of derivatives (12)   1,667  
Other (expense) / income, net (3) 32 (41) 156
Total other expense (4,090) (103) (7,175) (83)
Loss before income taxes (12,343) (27,481) (28,322) (47,927)
Income tax expense (178) (157) (299) (291)
Net loss and comprehensive loss (12,521) (27,638) (28,621) (48,218)
Net loss attributable to ordinary shareholders $ (12,521) $ (27,638) $ (28,621) $ (48,218)
Net loss per share attributable to ordinary shareholders – basic and diluted $ (0.80) $ (1.93) $ (1.87) $ (3.37)
Weighted average ordinary shares outstanding – basic and diluted 15,614,767 14,340,231 15,295,141 14,316,497